PTI
New Delhi, 26 January
Official sources said that the price of Covishield and Covaxin, the Covid vaccines, which are expected to get regular market approval from India’s drug regulator soon, is likely to be Rs 275 per dose and an additional service charge of Rs 150.
According to him, the National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines affordable.
As of now, Covaxin costs Rs 1,200 per dose, while CoviSheeld costs Rs 780 in private facilities. Prices include a service charge of Rs 150. Both vaccines are authorized for emergency use only in the country.
On January 19, the Central Drugs Standard Control Organization’s subject expert committee on COVID-19 recommended routine market approval of the Covid vaccines Covishield and Covaxin for use in the adult population, subject to certain conditions.
“NPPA has been asked to work towards capping the price of vaccines. The price is likely to be capped at Rs 275 per dose and an additional service charge of Rs 150.
Serum Institute of India Director (Government and Regulatory Affairs) Prakash Kumar Singh submitted an application to the Drugs Controller General of India on October 25, seeking regular market approval for its Kovidhield vaccine.
A few weeks ago, Bharat Biotech’s whole-time director V Krishna Mohan sought regular market authorization for Covaxin, with pre-clinical and clinical data as well as full details on chemistry, formulation and control. presented.
Covaxin and Covishield were granted Emergency Use Authorization (EUA) on 3 January last year. ,
#hat
#corona
#coronavirus
#covaxin
#cowishield
#Price
#Vaccination